To hear about similar clinical trials, please enter your email below
Trial Title:
Advice of Moderate Drinking Pattern Versus Advice on Abstention on Major Disease and Mortality
NCT ID:
NCT06338215
Condition:
All Cause Mortality
Cardiovascular Diseases
Invasive Cancer
Liver Cirrhosis
Type 2 Diabetes
Depression
Dementia
Injury Traumatic
Tuberculosis
Infections
Conditions: Official terms:
Tuberculosis
Liver Cirrhosis
Cardiovascular Diseases
Wounds and Injuries
Conditions: Keywords:
Alcohol
Drinking Pattern
Abstention
Advice
Clinical Trial
Moderation
Mediterranean Alcohol Drinking Pattern
Study type:
Interventional
Study phase:
N/A
Overall status:
Not yet recruiting
Study design:
Allocation:
Randomized
Intervention model:
Parallel Assignment
Primary purpose:
Prevention
Masking:
Double (Care Provider, Outcomes Assessor)
Intervention:
Intervention type:
Behavioral
Intervention name:
Moderate Alcohol Drinking Pattern
Description:
Remotely Intensive intervention by specialized coaches (psychologists, dietitians, and
other health professionals) to promote a behavior change on alcohol consumption. Repeated
quarterly small group sessions and periodical personal interviews and educational videos,
during up to 4 years with 1 contact every 3 months.
Goals of intervention:
1. moderate consumption (7 or less drinks/wk for women, 14 or less drinks/wk for men)
of red wine (a drink=150 ml).
2. always during meals
3. spread out throughout the whole week, and
4. avoidance of binge-drinking episodes. No participant will be invited to start or
increase his/her alcohol intake.
Arm group label:
Abstention
Arm group label:
Moderation
Intervention type:
Behavioral
Intervention name:
Abstention
Description:
Remotely Intensive intervention by specialized coaches (psychologists, dietitians, and
other health professionals) to promote a behavior change on alcohol consumption. Repeated
quarterly small group sessions and periodical personal interviews and educational videos,
during up to 4 years with 1 contact every 3 months.
Goals of intervention:
Abstention. Message of 0 alcohol.
Arm group label:
Abstention
Arm group label:
Moderation
Summary:
The goal of this clinical trial is to test two advices on alcohol drinking in more than
10.000 Spanish adult drinkers (men of 50 or more years and women of 55 or more years).
The main question it aims to answer is to test the non-inferiority advice of a moderate
alcohol drinking pattern on all-cause mortality and other chronic disease like
cardiovascular disease, cancer or type 2 diabetes.
Participants will receive during 4 years an advice to drink alcohol following a
Mediterranean Alcohol Drinking Pattern (MADP): consuming alcohol in moderation, avoidance
of binge drinking and preference for red wine.
Researchers will compare those who will receive a MADP advice with those who will receive
an advice on abstention to see if the advice on MADP is not inferior than the abstention
advice to prevent all-cause mortality and other chronic diseases.
Detailed description:
Policymakers and clinicians are currently perplexed on how to reduce alcohol harms in
drinkers, because of contradictory guidelines: abstention is proposed as the healthiest
option by many health advocates, stating that "there is no safe level of alcohol intake";
but most nonrandomized studies found lower all-cause mortality and other beneficial
outcomes in moderate drinkers than in abstainers among subjects >50 years.
However, potential biases may compromise these latter studies, particularly when effects
are null or moderate. A large pragmatic randomized controlled trial (RCT) of realistic
advice aimed to change behaviour addressing clinical endpoints is long overdue. It will
provide first-level evidence to confront the harms of one of the most widely used
substances by humankind.
The European Research Council has funded, through an Advanced Research Grant (2023-2028)
to the University of Navarra (Spain), as Host Institution, a 4-year non-inferiority RCT
with more than 10,000 drinkers (men 50-70 years or women 55-75 years consuming 3 or more
but 40 or less drinks/wk). The name of the trial is UNATI (University of Navarra Alumni
Trialist Initiative).
At least ten thousand drinkers will be randomized in a 1:1 ratio to repeatedly (4
contacts/year) receive during 4 years two different advices:
1. abstention;
2. moderation (7 or less drinks/wk in women and 14 or less drinks/wk in men), avoidance
of binge drinking, with preference for red wine consumed always with meals, and
consumption spread out throughout the week, following the traditional Mediterranean
Alcohol Drinking Pattern (MADP). Moderate consumption is hypothesized to be
non-inferior. No initiation or increment in alcohol intake will be promoted.
The primary endpoint will be a global index of all-cause mortality, cardiovascular
events, any invasive cancer, liver cirrhosis, type 2 diabetes, depression, dementia,
injury requiring hospital admission or tuberculosis or other infections requiring
hospitalization. As a secondary analysis, the most severe outcomes (mortality, invasive
cancer, stroke, myocardial infarction, liver cirrhosis) will be considered independently
with sufficient priority over less severe outcomes, using ad hoc methods.
The UNATI trial will provide for the first time an evidence-based answer to a question of
the utmost interest in clinical medicine, given the high prevalence of moderate alcohol
intake, and the current situation of equipoise with opposing views in the scientific
community on the most sensible advice for moderate drinkers. The starting date for the
project is December 1, 2023. The randomization of participants will start on June 2024.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- Males aged 50-70 years, Women aged 55-75 years
- Drinkers of any alcoholic beverage initially consuming 3 or more but 40 or less
drinks/wk
- Projected life expectancy more than 5 years (according to the judgment of their
attending physician)
- Willing to receive advice during up to 4 years on how to improve their alcohol
intake making it healthier
Exclusion Criteria:
1. Participants without smartphone or a computer (or tablet) with Internet connection.
2. Drinkers of less than 30 g of pure alcohol/wk or more than 400 g of pure alcohol/wk
3. Illiteracy, inability/unwillingness to give written consent or communicate with
study staff, or inadequate abilities for the use of on-line technologies
4. Participants with any sever psychiatric condition or with a diagnosis of cognitive
impairment or dementia.
5. Participants with liver cirrhosis or prior liver cancer.
6. Patients with a recent diagnosis of breast cancer (diagnosed in the last 10 years).
7. Patients under habitual use of high-dose medications that completely preclude any
use of alcohol. Most of these patients will be already excluded by the second or
fourth exclusion criteria.
Gender:
All
Minimum age:
50 Years
Maximum age:
75 Years
Healthy volunteers:
Accepts Healthy Volunteers
Locations:
Facility:
Name:
University of Navarra
Address:
City:
Pamplona
Zip:
31008
Country:
Spain
Contact:
Last name:
Estíbaliz Goñi, Nutritionist
Phone:
34948425600
Phone ext:
80-6596
Email:
egonioch@unav.es
Contact backup:
Last name:
Rafael Perez-Araluce, PharmD
Phone:
+34948425600
Phone ext:
80-6672
Email:
rperez.21@alumni.unav.es
Investigator:
Last name:
Miguel A Martinez-Gonzalez, MD, MPH, PhD
Email:
Principal Investigator
Start date:
May 1, 2024
Completion date:
June 30, 2029
Lead sponsor:
Agency:
Clinica Universidad de Navarra, Universidad de Navarra
Agency class:
Other
Source:
Clinica Universidad de Navarra, Universidad de Navarra
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06338215